The role of tumor necrosis factor-α receptors in atherosclerosis

Trends in Cardiovascular Medicine

Volumn 8, Issue 3, 1998, Pages 131-138

  LeBoeuf, Renee C ^a   Schreyer, Sandra A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ATHEROGENESIS; ATHEROSCLEROSIS; CELL TYPE; CYTOTOXICITY; IMMUNOREGULATION; INFLAMMATION; LYMPHOCYTE ACTIVATION; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SHORT SURVEY;

EID: 0031900951     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(97)00142-4     Document Type: Article

References (102)

1. Acton S, Rigotti A, Landschulz KT, et al.: 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271:518-520.
2. Barath P, Fishbein MC, Cao J, et al.: 1990a. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 65:297-302.
3. Barath P, Fishbein MC, Cao J, et al.: 1990b. Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization. Am J Pathol 137:503-509.
4. Bazzoni F, Beutler B: 1996. The tumor necrosis factor ligand and receptor families. N Engl J Med 334:1717-1725.
5. Benigni F, Faggioni R, Sironi M, et al.: 1996. TNF receptor p55 plays a major role in centrally mediated increases of serum IL-6 and corticosterone after intracerebroventrivular injection of TNF. J Immunol 157: 5563-5568.
6. Black RA, Rauch CT, Kozlosky CJ, et al.: 1997. A metalloproteinase disintegrin that releases tumor-necrosis-factor-alpha from cells. Nature 385:729-733.
7. Boldin MP, Goncharov TM, Goltsev YV, Wallach D: 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85:803-815.
8. Braun M, Pietsch P, Felix SB, Baumann G: 1995. Modulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 on human coronary smooth muscle cells by cytokines. J Mol Cell Cardiol 27:2571-2579.
9. Burress Welborn III M, Van Zee K, Edwards PD, et al.: 1996. A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon. J Exp Med 184:165-171.
10. Clinton SK, Underwood R, Hayes L, Sherman ML, Kufe DW, Libby P: 1992. Macrophage-colony stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol 140:301-316.
11. Decoster E, Vanhaesebroeck B, Vandenabeele P, Grooten J, Fiers W: 1995. Generation and biological characterization of membrane-bound, uncleavable murine tumor necrosis factor. J Biol Chem 270:18,473-18,478.
12. Duan H, Li Z, Mazzone T: 1995. Tumor necrosis factor-a modulates monocyte/macrophage apoprotein E gene expression. J Clin Invest 96:915-922.
13. Duverger N, Tremp G, Caillaud J-M, et al.: 1996. Protection against atherosclerosis in mice mediated by human apolipoprotein A-IV. Science 273:966-968.
14. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA: 1993. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268:11,811-11,816.
15. Erickson SL, de Sauvage FJ, Kikly K, et al.: 1994. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372:560-563.
16. Feingold KR, Serio MK, Adi S, Moser AH, Grunfeld C: 1989. Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. Endocrinology 124:2336-2342.
17. Feldmann M, Brennan FM, Williams RO, Elliott MJ, Maini RN: 1996. Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNFα antibody therapy and its mechanism of action. J Inflammation 47:90-96.
18. Fiers W, Beyaert R, Boone E, et al.: 1996. TNF-induced intracellular signaling leading to gene induction or to cytotoxicity by necrosis or by apoptosis. J Inflammation 47:67-75.
19. Furth PA, St. Onge L, Böger H, et al.: 1994. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 91:9302-9306.
20. Fyfe AI, Qiao J-H, Lusis AJ: 1994. Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. J Clin Invest 94:2516-2520.
21. Georgopoulos S, Plows D, Kollias G: 1996. Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. J Inflammation 46:86-97.
22. Giuffre L, Cordey AS, Monai N, Tardy Y, Schapira M, Spertini O: 1997. Monocyte adhesion to activated aortic endothelium: role of L-selectin and heparan sulfate proteoglycans. J Cell Biol 136:945-956.
23. Gossen M, Bujard H: 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547-5551.
24. Grell M: 1996. Tumor necrosis factor (TNF) receptors in cellular signaling of soluble and membrane-expressed TNF. J Inflammation 47:8-17.
25. Grell M, Douni E, Wajant H, et al.: 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793-802.
26. Grundy SM: 1997. Prevention of coronary heart disease through cholesterol reduction. Am Fam Physician 55:2250-2258.
27. Heller RA, Song K, Fan N, Chang DJ: 1992. The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 70:47-56.
28. Hsu H, Huang J, Shu HB, et al.: 1996a. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4:387-396.
29. Hsu H, Shu H-B, Pan M-G, Goeddel DV: 1996b. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84:299-308.
30. Hsu H-Y, Nicholson AC, Hajjar DP: 1996. Inhibition of macrophage scavenger receptor activity by tumor necrosis factor-alpha is transcriptionally and post-transcriptionally regulated. J Biol Chem 271:7767-7773.
31. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J: 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 92:883-893.
32. Jacobsen FW, Dubois CM, Rusten LS, Veiby OP, Jacobsen SE: 1995. Inhibition of stem cell factor-induced proliferation of primitive murine hematopoietic progenitor cells signaled throught he 75-kilodalton tumor necrosis factor receptor: regulation of c-kit and p53 expression. J Immunol 154:3732-3741.
33. Jovinge S, Hultgaardh-Nilsson A, Regnstrom J, Nilsson J: 1997. Tumor necrosis factor-alpha activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta. Arterioscler Thromb Vase Biol 17:490-497.
34. Joyce DA, Steer JH: 1995. Tumor necrosis factor alpha and interleukin-1 alpha stimulate late shedding of p75 TNF receptors but not p55 TNF receptors from human monocytes. J Interferon Cytokine Res 15:947-954.
35. Kaartinen M, Penttila A, Kovanen PT: 1996. Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha. Circulation 94:2787-2792.
36. Kriegler M, Perez C, DeFay K, Albert I, Lu SD: 1988. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53:45-53.
37. Lakso M, Sauer B, Mosinger B Jr, et al.: 1992. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci USA 89:6232-6236.
38. Li H, Freeman MW, Libby P: 1995. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J Clin Invest 95:122-133.
39. Liao F, Andalibi A, deBeer FC, Fogelman AM, Lusis AJ: 1993. Genetic control of inflammatory gene induction and NF-κB-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 91:2572-2579.
40. Libby P, Galis ZS: 1995. Cytokines regulate genes involved in atherogenesis. Ann NY Acad Sci 748:158-168.
41. Lichtman AH, Cybulsky M, Luscinskas FW: 1996. Immunology of ahterosclerosis: the promise of mouse models. Am J Pathol 149:351-357.
42. Liu Z, Hsu H, Goeddel DV, Karin M: 1996. Dissection of the TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NK-KB activation prevents cell death. Cell 87:565-576.
43. Mackay F, Loetscher H, Stueber D, Gehr G, Lesslauer W: 1993. Tumor necrosis factor a (TNF-α)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med 177:1277-1286.
44. Mackay F, Rothe J, Bluethmann H, Loetscher H, Lesslauer W: 1994. Differential responses of fibroblasts from wild-type and TNF-R55-deficient mice to mouse and human TNF-alpha activation. J Immunol 153:5274-5284.
45. Mak TW: 1995. Gaining insights into the ontogeny and activation of T cells through the use of gene-targeted mutant mice. J Inflammation 45:79-84.
46. Marczin N, Antonov A, Papapetropoulos A, et al.: 1996. Monocyte-induced downregulation of nitric oxide synthase in cultured aortic endothelial cells. Arterioscler Thromb Vasc Biol 16:1095-1103.
47. Matsumoto M, Mariathasan S, Nahm MH, Baranyay F, Peschon JJ, Chaplin DD: 1996. Role of lymphotoxin and the Type I TNF receptor in the formation of germinal centers. Science 271:1289-1291.
48. Maziere C, Auclair M, Maziere JC: 1994. Tumor necrosis factor enhances low density lipoprotein oxidative modification by monocytes and endothelial cells. FEBS Lett 338: 43-46.
49. Miller AR, Suttles J, Stout RD: 1996. Cytokine priming reduces dependence on TNF-R2 for TNF-alpha-mediated induction of macrophage nitric oxide generation. J Interferon Cytokine Res 16:1055-1063.
50. Mohamed F, Monge JC, Gordon A, Cernacek P, Biais D, Steward DJ: 1995. Lack of role for nitric oxide (NO) in the selective destabilization of endothelial NO synthase mRNA by tumor necrosis factor-alpha. Arterioscler Thromb Vase Biol 15:52-57.
51. Moss ML, Jin SL, Milla ME, et al.: 1997. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385:733-736.
52. Neumann B, Luz A, Pfeffer K, Holzmann B: 1996a. Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor. J Exp Med 184:259-264.
53. Neuman B, Machleidt T, Lifka A, et al.: 1996b. Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J Immunol 156:1587-1593.
54. O'Brien KD, Deeb SS, Ferguson M, et al.: 1994. Apopolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase. Am J Pathol 144:538-548.
55. Orban PC, Chui D, Marth JD: 1992. Tissue-and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci USA 89:6861-6865.
56. Paigen B: 1995. Genetics of responsiveness to high-fat and high-cholesterol diets in the mouse. Am J Clin Nutr 62:458S-462S.
57. Paigen B, Ishida BY, Verstuyft J, Winters RB, Albee D: 1990. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Arteriosclerosis 10:316-323.
58. Paleolog EM, Delasalle SA, Buurman WA, Feldmann M: 1994. Functional activities of receptors for tumor necrosis factor-alpha on human vascular endothelial cells. Blood 84:2578-2590.
59. Peraldi P, Hotamisligil GS, Buurman WA, White MF, Spiegelman BM: 1996. Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 271:13,018-13,022.
60. Pfeffer K, Matsuyama T, Kündig TM, et al.: 1993. Mice deficient for the 55 kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-467.
61. Plump AS, Smith JD, Hayek T, et al: 1992. evere hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71:343-353.
62. Pober JS, Gimbrone MA Jr, Lapierre LA, et al.: 1986. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor and immune interferon. J Immunol 137:1893-1896.
63. Rajavashisth TB, Andalibi A, Territo MC, et al.: 1990. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344:254-257.
64. Ramprasad MP, Fischer W, Witztum JL, et al.: 1995. The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci USA 92:9580-9584.
65. Ramprasad MP, Terpstra V, Kondratenko N, et al.: 1996. Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized; low density lipoprotein. Proc Natl Acad Sci USA 93:14,833-14,838.
66. Resnick D, Chatterton JE, Schwartz K, Slayter H, Krieger M: 1996. Structures of class A macrophage scavenger receptors. J Biol Chem 271:26,924-26,930.
67. Rosenfeld M, Ylä-Herttuala S, Lipton B, Ork V, Wifztum J, Steinberg D: 1992a. Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. Am J Pathol 140:291-300.
68. Rosenfeld ME, Tsukada T, Chait A, Bierman EL, Gown AM, Ross R: 1987. Fatty streak expansion and maturation in Watanabe heritable hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 7:24-34.
69. Rosenfeld ME, Carew TE, von Hodenberg E, Pittman RC, Ross R, Steinberg D: 1992b. Autoradiographic analysis of the distribution of 1251-tyramine-cellobiose-LDL in atherosclerotic lesions of the WHHL rabbit. Arterioscler Thromb 12:985-995.
70. Rothe J, Lesslauer W, Lötscher H, et al.: 1993. Mice lacking the tumor necrosis factor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798-802.
71. Rothe M, Pan M-G, Henzel WJ, Ayers TM, Goeddel DV: 1995a. The TNFR2-TRAF signaling complex contains two novel proteins related to Baculoviral inhibitor of apoptosis proteins. Cell 83:1243-1252.
72. Rothe M, Sarma V, Dixit VM, Goeddel DV: 1995b. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269:1424-1427.
73. Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM: 1991. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature 353:265-267.
74. Rutledge JC, Goldberg IJ: 1994. Lipoprotein lipase (LPL) affects low density lipoprotein (LDL) flux through vascular tissue: evidence that LPL increases LDL accumulation in vascular tissue. J Lipid Res 35: 1152-1160.
75. Rutledge JC, Woo MM, Rezai AA, Curtiss LK, Goldberg IJ: 1997. Lipoprotein-lipase increases lipoprotein binding to the artery wall and increases endothelial layer permeability by formation of lipolysis products. Circ Res 80:819-828.
76. Sauer B, Henderson N: 1988. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage Pl. Proc Natl Acad Sci USA 85:5166-5170.
77. Schreyer SA, Peschon JJ, LeBoeuf RC: 1996. Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55. J Biol Chem 271:26,174-26,178.
78. Sheurich P, Thoma B, Ucer U, Pfizenmaier K: 1987. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF-α): induction of TNF-α receptors on human T cells and TNF-α-mediated enhancement of T cell responses. J Immunol 138: 1786-1790.
79. Slowik MR, De Luca LG, Fiers W, Pober JS: 1993. Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration. Am J Pathol 143:1724-1730.
80. Stanton LW, White RT, Bryant CM, Protter AA, Endemann G: 1992. A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein. J Biol Chem 267:22,446-22,451.
81. Suzuki H, Kurihara Y, Takeya M, et al.: 1997. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386:292-296.
82. Takakuwa T, Knopt HP, Sing A, Carsetti R, Galanos C, Freudenberg MA: 1996. Induction of CD14 expression in Lpsn, Lpsd and tumor necrosis factor receptor-deficient mice. Eur J Immunol 26:2686-2692.
83. Tanaka H, Sukhova G, Schwartz D, Libby P: 1996. Proliferating arterial smooth muscle cells after balloon injury express TNF-α but not interleukin-1 or basic fibroblast growth factor. Arterioscler Thromb Vase Biol 16: 12-18.
84. Tanner WGa Wellborn MB, Shepherd VL: 1992. Tumor necrosis factor-alpha and interleukin-1 alpha synergistically enhance phorbol myristate acetate-induced superoxide production by rat bone marrow-derived macrophages. Am J Respir Cell Mol Biol 7:379-384.
85. Tartaglia LA, Goeddel DV: 1992. Two TNF receptors. Immunol Today 13:151-153.
86. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Polladino MA Jr, Goeddel DV: 1991. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 88:9292-9296.
87. Tartaglia LA, Goeddel DV, Reynolds C, et al.: 1993a. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J Immunol 151:4637-4641.
88. Tartaglia LA, Pennica D, Goeddel DV: 1993b. Ligand passing: the 75-kDa tumor necrosis factor receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 268:18,542-18,548.
89. Tartaglia LA, Rothe M, Hu Y-F, Goeddel DV: 1993c. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 73:213-216.
90. Tengku-Muhammad TS, Hughes TR, Cryer A, Ramji DP: 1996. Differential regulation of lipoprotein lipase in the macrophage J774.2 cell line by cytokines. Cytokine 8:525-533.
91. Ting AT, Pimentel-Muiños FX, Seed B: 1996. RIP mediates tumor necrosis factor receptor 1 activation of NF-KB but not Fas/APO-1-initiated apoptosis. EMBO J 15:6189-6196.
92. Van Lenten BJ, Fogelman AM: 1992. Lipopolysaccharide-induced inhibition of scavenger receptor expression in human monocyte-macrophages is mediated through tumor necrosis factor-alpha. J Immunol 148:112-116.
93. Van Zee KJ, Stackpole SA, Montegut WJ, et al.: 1994. A human tumor necrosis factor (TNF) a mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon. J Exp Med 179:1185-1191.
94. Vieira LQ, Goldschmidt M, Nashleanas M, Pfeffer K, Mak T, Scott P: 1996. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J Immunology 157:827-835.
95. Wang B, Kondo S, Shivji GM, Fujisawa H, Mak TW, Sauder DN: 1996. Tumour necrosis factor receptor II (p75) signalling is required for the migration of Langerhans' cells. Immunology 88:284-288.
96. Warden CH, Hedrick CC, Qiao JH, Castellani LW, Lusis AJ: 1993. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science 261:469-472.
97. Warner SJ, Libby P: 1989. Human vascular smooth muscle cells: target for and source of tumor necrosis factor. J Immunol 142: 100-109.
98. Williams LM, Gibbons DL, Gearing A, Maini RN, Feldmann M, Brennan FM: 1996. Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNFα processing in RA synovial membrane cell cultures. J Clin Invest 97:2833-2841.
99. Zhang SH, Reddick RL, Piedrahita JA, Maeda N: 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 248:468-471.
100. Zhang Y, Harada A, Bluethmann H, et al.: 1995. Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: increase of early hematopoietic progenitor cells in TNF receptor p55-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNF alpha in vitro. Blood 86:2930-2937.
101. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ: 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348-351.
102. Zuckerman SH, O'Neal L: 1994. Endotoxin and GM-CSF-mediated down-regulation of macrophage apoE secretion is inhibited by a TNF-specific monoclonal antibody. J Leukocyte Biol 55:743-748.